Are you passionate about turning molecular discoveries into real-world medical impact? Leiden University Medical Center (LUMC) is offering a PhD Candidate Position in Identification and Validation of Presymptomatic Biomarkers for Fibrosis.
Applicants must hold a master’s degree in Biology, Biochemistry, Biomedical Sciences, Bioinformatics, Bioengineering, or a related field. They should have a strong interest in metabolic diseases such as obesity or liver fibrosis, be motivated to develop skills in data science and omics analysis, and possess good communication and research presentation skills.
Leiden University Medical Center (LUMC) is a leading academic hospital in the Netherlands, known for combining top-quality healthcare, education, and research. As part of Leiden University, LUMC focuses on translating scientific discoveries into clinical innovations that improve patient care.
Established in 1575, Universiteit Leiden (Leiden University) is a non-profit public higher education institution located in the urban setting of the large town of Leiden (population range of 50,000-249,999 inhabitants), South Holland. This institution has also branch campuses in the following location(s): The Hague. Officially accredited and/or recognized by the Ministerie van Onderwijs, Cultuur en Wetenschap, Nederland (Ministry of Education, Culture and Science, Netherlands), Universiteit Leiden (LEI) is a large (uniRank enrollment range: 25,000-29,999 students) coeducational higher education institution. Universiteit Leiden (LEI) offers courses and programs leading to officially recognized higher education degrees such as bachelor degrees, master degrees, doctorate degrees in several areas of study. See the uniRank degree levels and areas of study matrix below for further details. This 444 years old higher-education institution has a selective admission policy based on students' past academic record and grades. International applicants are eligible to apply for enrollment.